Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
PUT
Hasbro
HAS
$13.4B
| $4.1M | ﹤0.01% |
50,000
| – | – |
|
2352
Kura Oncology
KURA
$896M
| $4.1M | ﹤0.01% |
394,605
+17,726
| +5% | +$186K |
|
2353
CALL
Humana
HUM
$46.2B
| $4.1M | ﹤0.01% |
16,000
-22,500
| -58% | -$5.9M |
|
2354
CALL
Generac Holdings
GNRC
$12.8B
| $4.09M | ﹤0.01% |
30,000
| – | – |
|
2355
Sensata Technologies
ST
$6.72B
| $4.09M | ﹤0.01% |
122,868
-27,959
| -19% | -$894K |
|
2356
CALL
Zoetis
ZTS
$31.3B
| $4.09M | ﹤0.01% |
32,500
| – | – |
|
|
2357
PUT
Zoetis
ZTS
$31.3B
| $4.09M | ﹤0.01% |
32,500
| – | – |
|
2358
Papa John's
PZZA
$804M
| $4.09M | ﹤0.01% |
106,159
+39,277
| +59% | +$1.73M |
|
2359
Standex International
SXI
$4B
| $4.08M | ﹤0.01% |
18,763
+1,703
| +10% | +$395K |
|
|
FOUR.PRA
2360
Shift4 Payments Inc 6.00% Series A Preferred Stock
FOUR.PRA
$615M
| $4.08M | ﹤0.01% |
50,947
+33,548
| +193% | +$2.94M |
|
2361
CALL
VF Corp
VFC
$5.79B
| $4.07M | ﹤0.01% |
+225,000
| New | +$3.65M |
|
|
2362
PUT
VF Corp
VFC
$5.79B
| $4.07M | ﹤0.01% |
+225,000
| New | +$3.65M |
|
2363
NewMarket
NEU
$8.72B
| $4.05M | ﹤0.01% |
5,899
-2,854
| -33% | -$2.18M |
|
2364
Perdoceo Education
PRDO
$1.96B
| $4.05M | ﹤0.01% |
138,082
+15,771
| +13% | +$498K |
|
2365
Willdan Group
WLDN
$1.29B
| $4.05M | ﹤0.01% |
39,057
+9,181
| +31% | +$904K |
|
2366
Newmark Group
NMRK
$2.68B
| $4.04M | ﹤0.01% |
233,264
+3,866
| +2% | +$67.7K |
|
2367
iShares MSCI China ETF
MCHI
$6.14B
| $4.04M | ﹤0.01% |
67,218
+45,041
| +203% | +$2.83M |
|
2368
Credit Acceptance
CACC
$6.05B
| $4.02M | ﹤0.01% |
9,062
-1,200
| -12% | -$556K |
|
2369
Park National Corp
PRK
$3.75B
| $4.02M | ﹤0.01% |
26,400
+4,346
| +20% | +$684K |
|
|
BNY
2370
PUT
Bank of New York Mellon
BNY
$110B
| $4.02M | ﹤0.01% |
+34,600
| New | +$3.83M |
|
2371
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.4B
| $4.01M | ﹤0.01% |
111,030
-47,433
| -30% | -$1.57M |
|
2372
iShares MSCI Singapore ETF
EWS
$1.16B
| $4.01M | ﹤0.01% |
145,620
-15,900
| -10% | -$447K |
|
2373
Leonardo DRS
DRS
$11.9B
| $4M | ﹤0.01% |
117,343
-10,804
| -8% | -$399K |
|
2374
Banner Corp
BANR
$2.5B
| $3.99M | ﹤0.01% |
63,754
-1,525
| -2% | -$96.3K |
|
2375
OneSpaWorld
OSW
$2.73B
| $3.99M | ﹤0.01% |
192,516
+20,122
| +12% | +$421K |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.